載入...
The JAK kinase inhibitor CP‐690,550 supresses the growth of human polycythemia vera cells carrying the JAK2(V617F) mutation
The somatic activating janus kinase 2 mutation (JAK2)(V617F) is detectable in most patients with polycythemia vera (PV). Here we report that CP‐690,550 exerts greater antiproliferative and pro‐apoptotic activity against cells harboring JAK2(V617F) compared with JAK2(WT). CP‐690,550 treatment of muri...
Na minha lista:
發表在: | Cancer Sci |
---|---|
Main Authors: | , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Blackwell Publishing Asia
2008
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829954/ https://ncbi.nlm.nih.gov/pubmed/18482053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2008.00817.x |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|